4//SEC Filing
REGEN BIOLOGICS INC 4
Accession 0001209191-08-023641
CIK 0000883697operating
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 3:17 PM ET
Size
6.9 KB
Accession
0001209191-08-023641
Insider Transaction Report
Form 4
Dichiara John
SR. VICE PRESIDENT
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2008-04-05+10,841→ 10,841 totalExercise: $16.00Exp: 2018-04-05→ Series E Convertible Preferred Stock (10,841 underlying)
Footnotes (4)
- [F1]EXERCISE PRICE IS $0.16 PER SHARE OF COMMON STOCK IF OPTION IS EXERCISED AFTER MANDATORY CONVERSION OF SERIES E STOCK.
- [F2]EQUAL TO 1,084,100 SHARES OF COMMON STOCK AFTER MANDATORY CONVERSION OF THE SERIES E STOCK
- [F3]THE OPTION VESTS RATABLY ON A DAILY BASIS OVER FOUR YEARS FROM THE DATE OF FDA CLEARANCE OF THE COLLAGEN SCAFFOLD 510(K) APPLICATION.
- [F4]EACH SHARE OF SERIES E STOCK IS MANDATORILY CONVERTIBLE INTO 100 SHARES OF REGEN'S COMMON STOCK AT SUCH TIME AS (i) THE COMPANY'S CERTIFICATE OF INCORPORATION IS AMENDED TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK OR (ii) UPON THE EFFECTIVENESS OF A REVERSE STOCK SPLIT OF THE COMMON STOCK, SUCH THAT THERE ARE A SUFFICIENT NUMBER OF SHARES OF COMMON STOCK TO EFFECT THE CONVERSION.
Documents
Issuer
REGEN BIOLOGICS INC
CIK 0000883697
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000883697
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 3:17 PM ET
- Size
- 6.9 KB